Preparation :
|
Produced in BALB/c mice using highly pure (>98%) recombinant human VEGF165
as the immunizing antigen. This IgG1K
antibody was purified from cell culture by Protein A chromatography.
|
Catalog #:
|
500-M88
|
Source :
|
Mice
|
Formulation :
|
A sterile filtered antibody solution was lyophilized from PBS.
|
Stability :
|
The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20o
C. Frozen aliquots are stable for at least six weeks at 2-8o
C or for at least six months at -20o
C. Avoid repeated freeze-thaw cycles.
|
Reconstitution:
|
Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 1.0 mg/ml.
|
Applications :
|
|
Selected References :
|
Selected List of References Citing This Product
|
Neutralization
|
To yield one-half maximal inhibition [ND
50
] of the biological activity of Human VEGF (10.0 ng/ml), a concentration of <0.2 μg/ml of this antibody is required.
|
Elisa
|
In a sandwich ELISA (assuming 100ul/well), a concentration of 2.0-4.0 μg/ml of this antibody will detect at least 100 pg/ml of recombinant human VEGF165
when used with 's biotinylated antigen affinity purified anti-human VEGF165
(500-P10Bt) as the detection antibody at a concentration of approximately 0.25-1.0 μg/ml.
|
Western Blot
|
To detect hVEGF165
by Western Blot analysis this antibody can be used at a concentration of 0.25-0.50 μg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hVEGF165
is 0.25-0.50 ng/lane, under non-reducing conditions.
|
Country of Origin :
|
USA
|
|
|
|
|
|
|
|
Special Sizes:
Many products can be ordered in custom sizes. Please click here
to contact with your request.
|
|
Usage:
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
|